AI-generated summary
The authors studied human dermal fibroblast cells treated with photobiomodulation at 808 nm and hypericin-mediated photodynamic therapy, focusing on mitochondrial and autophagic proteins. They report that changes in autophagy markers and apoptosis-related proteins were observed, with switching between autophagy and apoptosis appearing dose-dependent. The authors suggest that photobiomodulation might preferentially induce autophagy in these noncancer cells.
- Who or what was studied
- Human dermal fibroblast cells (in vitro cell culture)
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study is a cell-culture investigation, so its findings cannot be directly extended to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Mitochondria, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.